# 'Thrombectomy in High-Risk Pulmonary Embolism - Device Versus Thrombolysis Netherlands': TORPEDO-NL

> **NCT06833827** · NA · RECRUITING · sponsor: **Leiden University Medical Center** · enrollment: 111 (estimated)

## Conditions studied

- Pulmonary Embolism Acute

## Interventions

- **DEVICE:** Catheter-directed thrombectomy (CDT)
- **DRUG:** thrombolysis therapy

## Key facts

- **NCT ID:** NCT06833827
- **Lead sponsor:** Leiden University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02
- **Primary completion:** 2028-01
- **Final completion:** 2029-01
- **Target enrollment:** 111 (ESTIMATED)
- **Last updated:** 2025-02-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06833827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06833827, "'Thrombectomy in High-Risk Pulmonary Embolism - Device Versus Thrombolysis Netherlands': TORPEDO-NL". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT06833827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*